Alphadyne Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Alphadyne Asset Management's VRTX Position: Q2 2026 in Review
Alphadyne Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 99% in Q2 2026, selling an estimated $3.92M and leaving 73 shares worth $36.3K. The position accounts for ﹤0.01% of the portfolio, ranked #836.
Alphadyne Asset Management first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.98M in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Alphadyne Asset Management held 73 shares of Vertex Pharmaceuticals worth $36.3K as of Q2 2026.
- Alphadyne Asset Management sold 8,849 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.92M.
- Vertex Pharmaceuticals made up ﹤0.01% of Alphadyne Asset Management's portfolio in Q2 2026, its #836 holding.
- Alphadyne Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Alphadyne Asset Management's Vertex Pharmaceuticals position peaked at $3.98M in Q1 2026.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.